Refining targeted therapeutic approaches in pancreatic cancer: from histology and molecular pathology to the clinic-Reference-Cited by-同舟云学术

Refining targeted therapeutic approaches in pancreatic cancer: from histology and molecular pathology to the clinic

Published:2021-12-30 Issue: Volume: Page:1-4
ISSN:1472-8222
Container-title:Expert Opinion on Therapeutic Targets
language:en
Short-container-title:Expert Opinion on Therapeutic Targets

Author:

Mattiolo Paola¹,Kryklyva Valentyna²^ORCID,Brosens Lodewijk A.²³,Mafficini Andrea¹⁴,Lawlor Rita T.⁴,Milella Michele⁵,Scarpa Aldo¹⁴,Corbo Vincenzo¹,Luchini Claudio¹⁴^ORCID

Affiliation:

1. Department of Diagnostics and Public Health, Section of Pathology, University and Hospital Trust of Verona, Verona, Italy

2. Department of Pathology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands

3. Department of Pathology, University Medical Center Utrecht, Utrecht University, The Netherlands

4. ARC-Net Research Center, University and Hospital Trust of Verona, Verona, Italy

5. Department of Medicine, Section of Oncology, University and Hospital Trust of Verona, Verona, Italy

Funder

Fondazione Cariverona: Oncology Biobank Project “Antonio Schiavi”

Fondazione Italiana Malattie Pancreas

Italian Ministry of Health

Dutch Cancer Society

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14728222.2022.2021397

Reference20 articles.

1. Pancreatic cancer

2. Next generation sequencing of pancreatic ductal adenocarcinoma: right or wrong?

3. ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach

4. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade

5. Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular pathology and clinical implications

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genomic determinants of biological aggressiveness and poor prognosis of pancreatic cancers: KRAS and beyond;Expert Review of Molecular Diagnostics;2024-05-03

2. Microsatellite instability in pancreatic and ampullary carcinomas: histology, molecular pathology, and clinical implications;Human Pathology;2023-02

3. Tailored biological treatment for patients with moderate-to-severe psoriasis;Expert Review of Clinical Immunology;2022-11-09

4. NFL-TBS.40-63 Peptide Gold Complex Nanovector: A Novel Therapeutic Approach to Increase Anticancer Activity by Breakdown of Microtubules in Pancreatic Adenocarcinoma (PDAC);ACS Pharmacology & Translational Science;2022-10-14

5. Undifferentiated Sarcomatoid Carcinoma of the Pancreas: From Histology and Molecular Pathology to Precision Oncology;International Journal of Molecular Sciences;2022-01-24